Discovery
Building on our successful track record of delivering clinical candidates, we are expanding our medicinal chemistry service and introducing a new fragment screening platform, the CEfrag Screen
Selcia Discovery has significant research partnerships with leading pharmaceutical and biotechnology companies as well as academic institutions. We specialise in providing the medicinal chemistry resource for small biotech companies and academic institutions. At the same time we continue to expand our partnerships with major companies for drug discovery projects in all therapeutic areas.
We will be pleased to provide consultancy and advice to help with your grant and funding applications
Dr Bob Carling, Head of Medicinal Chemistry
Our synthetic chemistry work is backed up by the highest quality analytical service from our GLP accredited analytical laboratory. In addition all drug discovery activities are supported by internal functions, for example protein expression, structural biology, structural elucidation.
Selcia are attending the Biotech Outsourcing Strategy (BOS) conference 2010 in London UK on 21 September 2010.
Selcia is attending the VisionGain Cell-based Assays conference in London, UK from 20-22 September 2010.
Since 2008 Selcia Discovery has been working successfully on a EEDA funded drug discovery project.
